Home

Lawrence Erik Kurzius

CIK 1352090 · Chairman & CEO · last filed 2026-09-17

Lawrence Erik Kurzius is a Chairman & CEO who has filed 169 SEC Form 4 insider transactions across 5 companies since 2007. The most recent filing shows the insider bought $549.3K of COO on Sep 17, 2026. Across all open-market trades the lifetime net is −$85.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $21.2M across reported positions. 45 SEC filings were submitted jointly with Elanco Animal Health Inc.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$21.19M

Companies

5

Total Filings

169

Lifetime Open-Market Net

-$85.74M

Filer Profile

Reported Address
24 SCHILLING ROAD
HUNT VALLEY, MD 21031
Related Filers
Elanco Animal Health Inc — 45 joint filings, latest 2026-08-21
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
COO Director 31,099 $56.07 $1.74M $1.39M 8 2026-09-17
ELAN Director 188,647 $22.57 $4.26M $1.60M 19 2026-08-21
MKC.V 10%+ Owner 296,992 $50.30 $14.94M -$88.73M 113 2026-08-12
LW Director 5,461 $45.04 $246.0K $0 2 2025-10-03
Elanco Animal Health Inc (ELAT) Delisted Director 52,916 $21.32 $1.13M $0 24 2023-01-03

Recent Filings

169 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-09-17 COO Buy (P) +10,000 $549.3K EDGAR
2026-09-15 COO Buy (P) +10,000 $539.1K EDGAR
2026-08-21 ELAN Buy (P) +40,000 $935.9K EDGAR
2026-08-12 MKC.V Mixed — -$752.7K EDGAR
2026-05-26 ELAN Grant (A) +16,874 $0 EDGAR
2026-04-06 COO Mixed +3,322 $0 EDGAR
2026-02-13 MKC.V Mixed — -$1.13M EDGAR
2026-01-21 MKC.V Grant (A) +50,230 $0 EDGAR
2026-01-14 MKC.V Mixed — -$873.5K EDGAR
2025-12-17 COO Buy (P) +2,000 $165.0K EDGAR
Showing 1–10 of 169
Page 1 of 17
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.